Potential mechanisms include reduced levels of circulating insulin, insulin-like growth factor-I (IGF-I), and inflammatory cytokines, in turn leading to reduced proliferation and increased apoptosis of prostate cancer cells [9–13]. The gene discussed is IGF1; the disease is prostate carcinoma.